Mongolia vs Saudi Arabia: Reported cases of paralytic polio by world region
Mongolia
0 cases
in 2023
Saudi Arabia
0 cases
in 2023
Mongolia rank
26th
Saudi Arabia rank
26th
Reported cases of paralytic polio by world region over time
- Mongolia
- Saudi Arabia
How they compare
Mongolia currently reports 0 cases against 0 cases in Saudi Arabia, a difference of 0 cases.
The two have swapped places 2 times across 43 shared years of data; in 1980 it was Saudi Arabia ahead.
Mongolia ranks 26th and Saudi Arabia ranks 26th of 199 countries.
Saudi Arabia has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Mongolia | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 11.78 cases | 86.67 cases | 74.89 cases | Saudi Arabia |
| 1990s | 0.5 cases | 2.1 cases | 1.6 cases | Saudi Arabia |
| 2000s | 0 cases | 0.2 cases | 0.2 cases | Saudi Arabia |
| 2010s | 0 cases | 0 cases | 0 cases | — |
| 2020s | 0 cases | 0 cases | 0 cases | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported cases of paralytic polio by world region, Mongolia or Saudi Arabia?
- Mongolia, at 0 cases against 0 cases in Saudi Arabia as of 2023.
- What is the difference in reported cases of paralytic polio by world region between Mongolia and Saudi Arabia?
- 0 cases, with Mongolia ahead.
- How many years of comparable data are there for Mongolia and Saudi Arabia?
- 43 years are reported by both, from 1980 to 2023.
- How do Mongolia and Saudi Arabia rank globally for reported cases of paralytic polio by world region?
- Mongolia ranks 26th and Saudi Arabia ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data, published as Reported cases of paralytic polio by world region. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases.